Carmel, IN, United States of America

Murat Günay

USPTO Granted Patents = 3 

Average Co-Inventor Count = 2.4

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Murat Günay: Innovator in Medication Delivery Devices

Introduction

Murat Günay is a notable inventor based in Carmel, IN (US). He has made significant contributions to the field of medication delivery devices, holding a total of 3 patents. His innovative designs focus on improving the efficiency and usability of drug delivery systems.

Latest Patents

Murat's latest patents include a medication delivery device that features both disposable and reusable portions. This device incorporates a therapeutic agent delivery assembly that can transition from a stowed configuration to a deployed configuration. The reusable portion is equipped with a first and second rack and pinion mechanism, allowing for precise actuation of the therapeutic agent delivery assembly. Another patent involves a drug delivery device cassette that includes a needle assembly and a cartridge. This cassette is designed to couple and decouple from a reusable module, enhancing its versatility. The device also features an orientation mechanism and an extendable needle assembly, ensuring controlled fluid communication during medication delivery.

Career Highlights

Murat Günay is currently employed at Eli Lilly and Company, where he continues to develop innovative solutions in the pharmaceutical industry. His work focuses on creating devices that enhance patient care and streamline the medication administration process.

Collaborations

Murat collaborates with talented individuals such as Matthew David Backfish and Jared Alden Judson. These partnerships contribute to the advancement of technology in medication delivery systems.

Conclusion

Murat Günay's contributions to the field of medication delivery devices exemplify his commitment to innovation and improving healthcare solutions. His patents reflect a deep understanding of the needs within the pharmaceutical industry, making him a valuable asset to Eli Lilly and Company.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…